These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36327883)

  • 21. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
    Peng W; Chen T; Dai W
    IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis.
    Li X; Ma J; Leng L; Han M; Li M; He F; Zhu Y
    Front Genet; 2022; 13():806842. PubMed ID: 35186034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
    Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
    Lin Y; Zhang W; Cao H; Li G; Du W
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
    Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
    Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRIM: A Web-Based System for Investigating Drug Response at the Molecular Level by Condition-Specific Multi-Omics Data Integration.
    Oh M; Park S; Lee S; Lee D; Lim S; Jeong D; Jo K; Jung I; Kim S
    Front Genet; 2020; 11():564792. PubMed ID: 33281870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping.
    Madhumita ; Paul S
    Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tightly integrated multiomics-based deep tensor survival model for time-to-event prediction.
    Zhang JZ; Xu W; Hu P
    Bioinformatics; 2022 Jun; 38(12):3259-3266. PubMed ID: 35445698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
    Zeng H; Chen L; Zhang M; Luo Y; Ma X
    Gynecol Oncol; 2021 Oct; 163(1):171-180. PubMed ID: 34275655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of five supervised feature selection algorithms leading to top features and gene signatures from multi-omics data in cancer.
    Bhadra T; Mallik S; Hasan N; Zhao Z
    BMC Bioinformatics; 2022 Apr; 23(Suppl 3):153. PubMed ID: 35484501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RedCDR: Dual Relation Distillation for Cancer Drug Response Prediction.
    Xu M; Zhu Z; Zhao Y; He K; Huang Q; Zhao Y
    IEEE/ACM Trans Comput Biol Bioinform; 2024; 21(5):1468-1479. PubMed ID: 38776197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
    Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
    Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches.
    Liu XY; Mei XY
    Front Bioeng Biotechnol; 2023; 11():1156372. PubMed ID: 37139048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving anti-cancer drug response prediction using multi-task learning on graph convolutional networks.
    Liu H; Peng W; Dai W; Lin J; Fu X; Liu L; Liu L; Yu N
    Methods; 2024 Feb; 222():41-50. PubMed ID: 38157919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DeepDRA: Drug repurposing using multi-omics data integration with autoencoders.
    Mohammadzadeh-Vardin T; Ghareyazi A; Gharizadeh A; Abbasi K; Rabiee HR
    PLoS One; 2024; 19(7):e0307649. PubMed ID: 39058696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
    Seal DB; Das V; Goswami S; De RK
    Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.